Next Article in Journal
The Microbiome Characterization of Edible Visceral Organs and Fresh Meat During Production in a Pig Processing Facility in Thailand
Previous Article in Journal
Cardiac Device-Related Infective Endocarditis Caused by Salmonella Infantis—Case Report and Review of Clinical and Epidemiologic Implications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Molecular and Genetic Analysis of the Increased Number of Genes for Trypanosoma cruzi Microtubule Associated Proteins in the Class Kinetoplastida

by
Martin A. Winkler
1,* and
Alfred A. Pan
2,*
1
Biotech Advisor, 1321 Wagon Wheel Road, Lawrence, KS 66049-3543, USA
2
TNTC, Inc., 25A Crescent Drive, Pleasant Hill, CA 94523-5508, USA
*
Authors to whom correspondence should be addressed.
Pathogens 2025, 14(5), 476; https://doi.org/10.3390/pathogens14050476
Submission received: 24 February 2025 / Revised: 25 April 2025 / Accepted: 12 May 2025 / Published: 14 May 2025
(This article belongs to the Special Issue Genetics and Molecular Evolution of Parasitic Protozoa)

Abstract

:
Trypanosoma cruzi GenBank® M21331 encodes for Antigen 36 (Ag 36), which is a tandemly repeated T. cruzi antigen. GenBank M21331 has a gene sequence similarity to human immune genes IFN-α, IFN-β, and IFN-γ, as well as to human TRIM genes. A BLAST-p search revealed that T. cruzi GenBank M21331 had seven gene sequences homologous to microtubule-associated protein (MAP) genes with a 100% amino acid sequence identity. There are 36 genes in the T. cruzi genome with >94% identity to GenBank M21331, and these genes encode proteins ranging in size from 38 to 2011 amino acids in length, the largest containing 20, 25, and 30 repeats of the Ag 36 thirty-eight-amino-acid-sequence motif. The purpose of this study was to perform a genetic and molecular comparative analysis of T. cruzi GenBank M21331 to determine if this gene sequence is unique to the T. cruzi clade, present in the T. brucei clade, and/or exists in other trypanosomatids. There are seven homologous genes to GenBank M21331 in T. cruzi, but only one homolog found of this gene in T. brucei. The MAP genes in T. cruzi appear to have expanded at least eleven-fold in number compared to similar MAP genes in T. brucei. The DNA sequences and functions of these MAP genes in their respective species and clades will be discussed and are a fascinating area for further scientific study.

1. Introduction

Trypanosomatid parasites in the class Kinetoplastida include Trypanosoma cruzi, T. brucei ssp., and Leishmania spp., are the causative human agents of Chagas disease, African sleeping sickness, and Leishmaniasis, respectively [1]. The genome sequences of these three trypanosomatids, T. cruzi, T. brucei, and L. major, are now available to aid in genetic, immunological, and molecular research [2,3,4,5]. In addition, a whole genome assembly of a hybrid Trypanosoma cruzi strain has been assembled with Nanopore sequencing [6]. Investigations into the biological mechanisms of T. cruzi are perplexing due to the multifaceted nature and unique characteristics of its genes. Trypanosoma cruzi is diploid, containing homologous chromosome pairs which are differentially sized [7]. Its genome has been sequenced and is estimated to be between 106.4 and 110.7 Mb in size (diploid) [2,3]. At least 50% of the genome contains repetitive sequences in simple tandem repeats and consists of a large family of surface proteins, gene retrotransposons, and subtelomeric repeats. These repetitive genes may also be found as secreted proteins which serve to evade the host immune responses that are expressed concurrently [8,9,10,11]. In addition, T. cruzi genes encode numerous families of surface proteins (e.g., mucins and mucin-associated surface proteins) [12,13,14,15,16], and their genes also encode trans-sialidases [10,11,13,14,15,16,17,18,19]. It is hypothesized that this strategy may assist the amastigote form of T. cruzi to survive and propagate in susceptible hosts by evading recognition by T-cells [20,21].
Trypanosoma cruzi exemplifies a genetically diverse intra-species [22,23,24,25]. Based on analysis of genetic and biochemical indicators, there may be up to seven lineages (Typing Units) of TcI–TcVI [26,27,28,29,30,31,32] and TcBat [33]. However, there is immunological evidence that Chagas disease may also be due to a single parasite lineage based on a small surface molecule [34]. These lineages may produce distinct pathological manifestations ranging from CCC (Chronic Chagas Cardiomyopathy) in endemic areas to enlargement of the esophagus and colon (known as mega syndromes). Typing Unit TcI (e.g., Sylvio X10/1 and Dm28c [35,36] and Dm25 [13]) belong to Typing Unit TcI, a group related to the sylvatic cycle that is associated with human disease in endemic countries north of the Amazon basin [36,37,38,39,40], and is also found in the transmission cycle between insect vector and animals. Typing Unit TcII mainly occurs in domestic settings in the southern countries of South America [36,38,40,41] and causes tissue damage of the internal organs and digestive tract [39,40,42]. These Typing Units could be used as a target for drug discovery and reverse genetics [43].
In 2005–2006, a resurgence in neglected diseases arose [44,45,46,47,48,49,50], and Chagas disease has now been referenced as “the most neglected of the neglected diseases” [50]. The recognition of these impactful but neglected parasitic diseases has resulted in increased research in the areas of immunology, molecular biology, and genetics being used to study and characterize host–parasite relationships, and to identify antigenic molecules which are involved in mounting a protective immune response. Today, an estimated 6 to 7 million human individuals and countless susceptible mammalian species are infected with this parasite. It has been estimated that an additional 75 million people may be at risk of infection [51] leading to approximately 12,000 deaths every year. However, at present, no vaccine has been approved for these diseases and available drugs are highly toxic, with severe and frequent side effects, and may only be effective in combating circulating forms of the parasite [52]. In addition, the occurrence of drug resistance is also a possibility. Therefore, there is an urgent necessity to identify gene, protein, and carbohydrate targets, and understand their mechanisms of action(s). These may result in unique and specific markers for vaccines, as well as in the development of therapeutics. There is also the need for the development of highly sensitive and specific analytical diagnostic assays in blood and tissue specimens to combat further spread of these diseases [53,54,55,56].
In earlier investigations of diagnostic antigens, we identified one cloned gene from T. cruzi (Brazil strain) amastigotes from axenic culture [57] as a potential candidate. These axenic amastigotes have been shown to be comparable to amastigotes in cell culture (MRC-5 and Vero cells) [17]. This gene was sequenced and found to be identical to the repetitive antigen Clone 36, “Antigen 36” [9,58,59,60], and was also described as JL9 Antigen [61]. An initial search of the Wisconsin Package [62] with our DNA sequence disclosed similarity to human Ro52 with the translated sequence in the second reading frame of Ag 36. Direct comparison of the Ag 36 DNA sequence with the Ro52 DNA sequence revealed a 70% identity in one sequence of 44 nucleotides between the Ag 36 DNA sequence and TRIM21, the gene for human Ro52 [58]. Once the function of TRIM21 was identified, we proposed that there may be a link between it and the gene for Ag 36 identified in CCC [58]. Ro52 is expressed in the immune system as a predominantly cytoplasmic protein that can be upregulated and translocated to the nucleus in a pro-inflammatory environment. A study was also conducted to compare TRIM21 region sequences among mammalian species to the human TRIM21 region to evaluate any similarities in non-human genes. Results indicated that related sequences were present in 11 mammalian species [60]. Additionally, a BLAST-p search was conducted with GenBank® M21331 against the T. cruzi genome to determine the minimum number of genes coding for proteins closely related to Ag 36. The BLAST-p revealed 7 unique GenBank accession entries which produced seven proteins 100% identical to Ag 36 of the 14 GenBank entries previously reported [60]. We have also shown that GenBank M21331 has a significantly similar gene sequence identity to human immune genes (IFN-α, IFN-β, and IFN-γ) and to human TRIM genes, such as TRIM40 and TRIM21 [60]. Those results appeared to be the first description of molecular mimicry of immune genes in humans by a protozoan parasite [60]. The protein generated from this gene has also been used in the development and implementation of a diagnostic assay [63,64,65].
A phylogenetic tree for these trypanosomatids was developed by Stevens [1], and indicated a T. cruzi clade, a T. brucei clade, and an aquatic clade. However, unfortunately no data are available in GenBank on the aquatic clade to perform a genetic comparison. Additional evolutionary history on T. cruzi is provided by Maslov [19], Briones [66], and Rozas [67]. In this study, we focus on a genetic and molecular comparative analysis of T. cruzi GenBank M21331 to organisms in the class Kinetoplastida to determine if this gene sequence is exclusive to members in the T. cruzi clade or is present in the T. brucei clade. Microtubule associated proteins are present in the T. cruzi clade, as designated above, and have also been described in trypanosomes present on the African continent, such as MARP-1 (a repetitive non-variable antigen) [68,69] that is localized on the microtubules of the parasite’s cell body and flagellum. MARP-1 comprises 50 repeats of a 38 amino acid motif in T. b. brucei and T. b. gambiense [70,71]. In addition, MAPs are present in other African trypanosomes such as T. vivax, T. congolense, T. evansi, and T. equiperdum, as well as New World trypanosomes, such as T. rangeli and T. theileri, and in Leishmania spp.
The Kinetoplastid groups of parasites diverged approximately 500 million years ago in different habitats worldwide [1,72]. It is also speculated that T. cruzi arose over 150 million years ago, infecting animals throughout Laurasia and Gondwanaland, which are the regions that eventually formed North and South America, respectively [66]. It is theorized that the disease occurred in humans approximately 15,000–20,000 years ago in the late Pleistocene era when they were migrating into these areas. These trypanosomatids have thus genetically evolved over millennia to each develop unique molecular mechanisms to evade destruction from the innate immune system of the host. GenBank M21331 and related genes in American and African trypanosomes are conserved as MAPs and can be used as genetic, immunological, and molecular biomarkers. The MAP genes, the DNA sequences, and their functional role in trypanosomes and in their respective species and clades are intriguing, and they will be further evaluated, investigated, and analyzed.

2. Materials and Methods

2.1. Cloning of Trypanosoma cruzi Amastigote Genes

We identified one cloned gene from Trypanosoma. cruzi (Brazil strain) amastigotes grown in axenic culture [57], characterized it [17], sequenced it by the Sanger method [73], and found it to be identical to the repetitive antigen Clone 36, “Antigen 36” [9,58,59,60].

2.2. BLAST-p Search to Determine Number of Ag 36 Homologues

The GenBank M21331 gene was translated into its amino acid sequence using the translation tool at https://usegalaxy.org (accessed on 25 March 2025) [74,75] and the sequence entered in the BLAST-p search box to determine homologous genes in the T. cruzi genome. The BLAST-p search algorithm was selected at https://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 25 March 2025). The search entered into the database read Trypanosoma cruzi taxid 5693, or Trypanosoma cruzi Dm28c taxid 1416333, and the first 100 most homologous genes (in order of their homology to GenBank M21331) and their amino acid sequences were downloaded and saved as a text file. The “e value” noted in Table 1 is the probability that this result happened by random chance.

2.3. BLAST-p Search of Trypanosoma brucei with Trypanosoma cruzi GenBank M21331

The GenBank M21331 gene was translated into its amino acid sequence using the translation tool at https://usegalaxy.org [74,75] and the sequence was entered in the BLAST-p search box to determine homologous genes in the T. brucei genome. The BLAST-p search algorithm was selected at https://blast.ncbi.nlm.nih.gov/Blast.cgi. The search entered into the database read Trypanosoma brucei taxid id 5691, and the first 100 most homologous genes (in order of their homology to GenBank M21331) and their amino acid sequences were downloaded and saved as a text file.

2.4. BLAST-p Search of Leishmania donovani with Trypanosoma cruzi GenBank M21331

The GenBank M21331 gene was translated into its amino acid sequence using the translation tool at https://usegalaxy.org [74,75] and the sequence was entered in the BLAST-p search box to determine homologous genes in the L. donovani genome. The BLAST-p search algorithm was selected at https://blast.ncbi.nlm.nih.gov/Blast.cgi. The search entered into the database read Leishmania donovani taxid id 5661, and the first 100 most homologous genes (in order of their homology to GenBank M21331) and their amino acid sequences were downloaded and saved as a text file.

3. Results

To determine the number of homologues of Ag 36 in the T. cruzi genome, a BLAST-p search of the https://blast.ncbi.nlm.nih.gov/Blast.cgi database with the Ag 36 protein sequence was conducted. It revealed 7 unique GenBank accession entries which produced seven proteins 100% identical to Ag 36 of the 14 GenBank entries previously reported [60], as shown in Table 1. There were no genes found with the BLAST-p of Dm28c [35] and other single genomes. Sylvio X10/1 [35,36] and Dm25 [13] were not available for a BLAST-p search in the NCBI database.
In addition, following the search of the T. cruzi genome at https://www.ncbi.nlm.nih.gov/, there were 36 genes with greater than 94% identity to GenBank M21331 (Table 2), with 35 proteins containing multiple copies of the Ag 36 sequence motif. These genes ranged from 38 to 2011 amino acids in length, as shown in Table 2. For each entry in Table 2, the number of repeats of the Ag 36 motif (identified as homologous domains by the BLAST-p search program) is shown in Table 3. There are repeats of 1–10, 11–12, 17, 19, 20, and 25 copies, and two entries have a maximum of 30 repeats. In the 36 entries shown in Table 3, there are a total of 296 total copies of the Ag 36 protein sequence motif. The high number of genes with multiple copies of the Ag 36 sequence may be due to the internal sequence duplication in the gene of Ag 36, GenBank M21331. The gene sequence coding for Ag 36 M21331 was obtained from its GenBank entry in FASTA format to indicate an internal duplication (Figure 1). The ten-nucleotide sequence is shown in blue faced font and highlighted twice is an internal duplication found in this gene and in its homologues. This internal sequence duplication may have increased the chance of unequal crossing over between two copies of the gene during meiosis, producing larger, duplicated genes [76]. It is of interest that meiosis has been reported in T. cruzi [77,78]. Figure 2 shows an example of a T. cruzi gene, GenBank PWU83737, with multiple (3) copies of the Ag 36 amino acid sequence.
This result allowed us to further explore the similarity of GenBank M21331 to genes in other species in the class Kinetoplastida MAPs. BLAST-p searches of Ag 36 amino acid sequences were also performed versus genomes of T. brucei (ssp.), T. congolense and L. donovani, T. theileri, and T. vivax. The resulting matches were ranked by percent identity to Ag 36 sequence and the highest percent identities are shown in Table 4. The highest percent identities are, therefore, most directly related to the Ag 36 sequence.

4. Discussion

The purpose of this study was to compare, enumerate, and analyze DNA sequences between T. cruzi GenBank M21331, which codes for Ag 36, and similar genes found in the class Kinetoplastida. We focused on a genetic and molecular comparative analysis of T. cruzi GenBank M21331 (Ag 36) to determine if this gene sequence is exclusive to members in the T. cruzi clade, or present in the T. brucei clade, and/or other trypanosomatids. A BLAST-p search of Ag 36 protein, versus the translated T. cruzi genome at the NCBI website, disclosed that there are 43 T. cruzi gene products (seven homologues and 36 genes containing multiple copies) that are homologous in protein sequence to Ag 36, implying that there are 43 genes that are very similar or identical to GenBank M21331 in T. cruzi. Thirty-six of the protein matches were greater in length than Ag 36 and contained one or more sequences homologous or partially homologous to Ag 36. A BLAST-p search of Ag 36 was performed on T. theileri, T. vivax, T. brucei, T. b. brucei, T. b. gambiense T. congolense, and Leishmania spp. genomes. Trypanosoma theileri and T. vivax showed 83 and 57% identities, in line with their close phylogenetic relationship to T. cruzi. Similarly, T. brucei, T. b. brucei, and T. b. gambiense showed proteins 69% homologous to Ag 36. Additionally, T. b. equiperdum and T. congolense had proteins 65% homologous to Ag 36, and L. donovani. Leishmania tropica and L. mexicana had proteins 47% homologous to Ag 36 (Table 4). These results show that there is an eleven-fold greater number of copies of the MAP genes related to GenBank M21331 in T. cruzi compared to T. brucei spp., from the following calculation: Fold of T. cruzi compared to T. brucei spp. = (7 T. cruzi homologues + 36 closely related genes)/(4 T. brucei spp. Genes) = 43/4 = 10.75. Trypanosoma cruzi strain Dm28c [35] provided no BLAST-p results, which implies that this strain and perhaps others in Typing Unit TcI do not have this gene and its homologues. Sylvio X10/1 [36], Dm25c [13], and other individual strains were not available at NCBI to be searched by a BLAST-p as a genome.
The specific and definitive roles these T. cruzi MAPs may play, besides their possible association with microtubules, is yet to be defined. However, based on the similarity of GenBank M21331 to IFNs, TRIM21 and other TRIM (tripartite motif) genes, GenBank M21331 mRNAs may play a crucial part in suppressing host mRNA translation of the IFN and TRIM genes that are involved in the innate immune response to T. cruzi [59,60]. Trypanosoma theileri, a closely related species to T. cruzi in the Kinetoplast phylogeny [1], showed a gene 83% identical to GenBank M21331. The most identical gene in T. theileri did not show the internal ten nucleotide repeat found in GenBank M21331 (excluding the overall repeats due to it being a repetitive antigen). There were no additional larger homologues of the T. theileri gene as were observed in T. cruzi with GenBank M21331. This finding supports the theory that the internal repeat in GenBank M21331 may have given rise to the additional larger homologues. Trypanosoma theileri is a blood borne trypanosome of cattle commonly transmitted by biting flies. It does not typically invade and does not reside inside of cells as T. cruzi does. Trypanosoma cruzi has an eleven-fold greater number of GenBank M21331 MAPs compared to T. brucei spp., which do not have an intracellular stage. Trypanosoma vivax, another parasitic disease of cattle and wild mammals that survives extracellularly in its host, disclosed three genes (986, 1318, and 2957 nucleotides in length) with 57% identity which were much larger when compared to GenBank M21331. The results in this study indicate that there are at least an eleven-fold greater number of copies of MAP genes related to GenBank M21331 in T. cruzi compared to T. brucei spp.
There may be up to seven lineages of T. cruzi from analysis of genetic, molecular, and biochemical indicators [22,23,24,25,26,27,30,31,32,33,34,35,36,37,39,41,42,43]. It is surprising that GenBank M21331 and its family of 43 homologous genes were not found in T. cruzi strain Dm28c [35], representative of Typing Unit TcI (sylvatic cycle). Either the genes related to GenBank M21331 were lost from this strain, or never gained them as in Typing Units TcII, III, V, and VI. The divergence between these genes in the typing groups may be a result of meiosis, which has been reported in T. cruzi [77,78], with genetic exchange occurring between lineages. Therefore, divergence can occur due to recombination between organisms once thought to reproduce asexually. However, due to biomarker and sequence analysis of conserved genes, a common genetic ancestor may eventually be identified.
The bioinformatics tools such as BLAST-p that have been utilized in this study have been shown to be powerful, and have been used extensively for investigations in immunology, infectious disease, drug discovery, and other areas of biomedical research [80]. In combination with recent genomic data, we have used bioinformatics to trace the phylogeny of genes related to GenBank M21331 in Trypanosomes, resulting in an eleven-fold greater number in most lineages of T. cruzi compared with T. brucei. The seven Typing Units of T. cruzi, TcI through TcVII and TcBat, have been associated by their epidemiology and ecological scenarios [13,81]. They can be distinguished in the laboratory by analysis of their kinetoplast mini-circles, nuclear DNA, and other genetic or electrophoretic markers [37,38,82,83]. Experiments can be designed to test the Ag 36 family of genes as a new marker to discriminate TcI from the other Typing Units. The GenBank M21331 gene has apparently been duplicated to form a family of 36 related genes in all Typing Units except for TcI. The absence of these genes in TcI is confirmed by negative immunoassay results for Ag 36 in TcI serum samples from Chagas patients, along with positive immunoassay results in the other Typing Units [63,64]. The Ag 36 family of genes, along with the Ag 36 serology, can be further used in laboratory experiments to compare infectivity and disease severity between Typing Units.
The Kinetoplastid groups of parasites diverged approximately 500 million years ago in different parts of the world [1,72]. Trypanosoma cruzi arose over 150 million years ago, infecting animals in North and South America [66]. GenBank M21331 and related genes are conserved as MAPs between American and African trypanosomes and can be useful as genetic, immunological, and molecular biomarkers. The T. cruzi MAP genes partial identities to human immune genes (IFN-α, IFN-β, IFN-γ, and human TRIM genes) may be relevant to the parasite’s resistance to the mammalian innate immune system during infection. Further experiments can be designed [60] to test GenBank M21331 and related genes for their role in resistance to innate immunity.

Author Contributions

Writing—original draft, M.A.W. and A.A.P. All authors have read and agreed to the published version of the manuscript.

Funding

The Galaxy server that was used for some calculations is in part funded by Collaborative Research Centre 992 Medical Epigenetics (DFG grant SFB 992/1 2012) and German Federal Ministry of Education and Research (BMBF grants 031 A538A/A538C RBC, 031L0101B/031L0101C de.NBI-epi, 031L0106 de.STAIR (de.NBI)).

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available in the online Galaxy repositories: https://usegalaxy.eu/u/martinawinklerphd/h/copy-of-copy-of-mammalian-trim-genes-compared-with-antigen-36 (accessed on 24 April 2025); https://usegalaxy.org/u/martinawinklerphd/h/ag36-and-mammalian-trim21-homologies (accessed on 24 April 2025). These bioinformatics workflows are available to all, but registration (which is free) is required to view the results.

Acknowledgments

The authors would like to thank Abbott Laboratories and our colleagues where the foundational investigations were performed, and to Diana Rivera for her thorough review and helpful comments and suggestions.

Conflicts of Interest

Author Martin A. Winkler was employed by the company Biotech Advisor. Author Alfred A. Pan was employed by the company TNTC, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

The following abbreviations and definitions are used in this manuscript: Antigen 36 (Ag 36)—(clone A2; clone 36; Tc36; JL9)—The tandemly repeated T. cruzi antigen reported by Ibañez [9], Levin [61], and Winkler [58,59,60], which is highly reactive with Chagasic sera [63,64]. GenBank M21331—GenBank® is a database that contains publicly available nucleotide sequences for genus/species organisms. The library is obtained through submissions from laboratories and batch submissions from large-scale sequencing projects. T. cruzi GenBank M21331 encodes for Antigen 36 (Ag 36). MAP (Microtubule Associated Proteins)—Microtubule associated proteins regulate assembly and stability of microtubules. Microtubules constitute a major part of the cytoskeleton and are important in cytoskeletal rearrangements during neuronal growth, axon guidance, and synapse formation. The Ag 36 gene of T. cruzi has seven homologous genes sequences (MAP genes with 100% amino acid sequence identity) to GenBank M21331. MARP-1 (Microtubule-Associated Repetitive Proteins)—The microtubular membrane framework of T. brucei containing two closely related, repetitive, high-molecular-weight MAPs, MARP-1 and MARP-2. The structure consists of a 38-amino-acid repeat over an approximate length of about 320 kDa, which are tandemly arranged and conserved.

References

  1. Stevens, J.R.; Noyes, H.A.; Dover, G.A.; Gibson, W.C. The ancient and divergent origins of the human pathogenic trypanosomes, Trypanosoma brucei and T. cruzi. Parasitology 1999, 118, 107–116. [Google Scholar] [CrossRef]
  2. El-Sayed, N.M.; Myler, P.J.; Bartholomeu, D.C.; Nilsson, D.; Aggarwal, G.; Tran, A.N.; Ghedin, E.; Worthey, E.A.; Delcher, A.L.; Blandin, G.; et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309, 409–415. [Google Scholar] [CrossRef]
  3. DeCuir, J.; Tu, W.; Dumonteil, E.; Herrera, C. Sequence of Trypanosoma cruzi reference strain SC43 nuclear genome and kinetoplast maxicircle confirms a strong genetic structure among closely related parasite discrete typing units. Genome 2021, 64, 525–531. [Google Scholar] [CrossRef]
  4. Berriman, M.; Ghedin, E.; Hertz-Fowler, C.; Blandin, G.; Renauld, H.; Bartholomeu, D.C.; Lennard, N.J.; Caler, E.; Hamlin, N.E.; Haas, B.; et al. The genome of the African trypanosome Trypanosoma brucei. Science 2005, 309, 416–422. [Google Scholar] [CrossRef]
  5. Ivens, A.C.; Peacock, C.S.; Worthey, E.A.; Murphy, L.; Aggarwal, G.; Berriman, M.; Sisk, E.; Rajandream, M.A.; Adlem, E.; Aert, R.; et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309, 436–442. [Google Scholar] [CrossRef]
  6. Hakim, J.M.C.; Guarnizo, S.A.G.; Machaca, E.M.; Gilman, R.H.; Mugnier, M.R. Whole genome assembly of a hybrid Trypanosoma cruzi strain assembled with Nanopore sequencing alone. G3 2023, 7, 550875, Erratum in G3 2024, 5, jkae076. [Google Scholar] [CrossRef]
  7. Pedroso, A.; Cupolillo, E.; Zingales, B. Evaluation of Trypanosoma cruzi hybrid stocks based on chromosomal size variation. Mol. Biochem. Parasitol. 2003, 129, 79–90. [Google Scholar] [CrossRef]
  8. De Pablos, L.M.; Osuna, A. Multigene families in Trypanosoma cruzi and their role in infectivity. Infect. Immun. 2012, 80, 2258–2264. [Google Scholar] [CrossRef]
  9. Ibañez, C.F.; Affranchino, J.L.; Macina, R.A.; Reyes, M.B.; Leguizamon, S.; Camargo, M.E.; Åslund, L.; Pettersson, U.; Frasch, A.C.C. Multiple Trypanosoma cruzi antigens containing tandemly repeated amino acid sequence motifs. Mol. Biochem. Parasitol. 1988, 30, 27–34. [Google Scholar] [CrossRef]
  10. Kahn, S.; Colbert, T.G.; Wallace, J.C.; Hoagland, N.A.; Eisen, H. The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases. Proc. Natl. Acad. Sci. USA 1991, 88, 4481–4485. [Google Scholar] [CrossRef]
  11. Kahn, S.J.; Nguyen, D.; Norsen, J.; Wleklinski, M.; Granston, T.; Kahn, M. Trypanosoma cruzi: Monoclonal antibodies to the surface glycoprotein superfamily differentiate subsets of the 85-kDa surface glycoproteins and confirm simultaneous expression of variant 85-kDa surface glycoproteins. Exp. Parasitol. 1999, 92, 48–56. [Google Scholar] [CrossRef] [PubMed]
  12. Di Noia, J.M.; Sanchez, D.O.; Frasch, A.C.C. The protozoan Trypanosoma cruzi has a family of genes resembling the mucin genes of mammalian cells. J. Biol. Chem. 1995, 270, 24146–24149. [Google Scholar] [CrossRef] [PubMed]
  13. Hoyos Sanchez, M.C.; Ospina Zapata, H.S.; Suarez, B.D.; Ospina, C.; Barbosa, H.J.; Carranza Martinez, J.C.; Vallejo, G.A.; Urrea Montes, D.; Duitama, J. A phased genome assembly of a Colombian Trypanosoma cruzi TcI strain and the evolution of gene families. Sci. Rep. 2024, 14, 2054. [Google Scholar] [CrossRef]
  14. Dean, A.A.C.; Berná, L.; Robello, C.; Buscaglia, A.C.; Balouz, V. An algorithm for annotation and classification of T. cruzi MASP sequences: Towards a better understanding of the parasite genetic variability. BMC Genom. 2025, 26, 194. [Google Scholar]
  15. Herreros-Cabello, A.; Callejas-Hernández, F.; Gironès, N.; Fresno, M. Trypanosoma cruzi: Genomic diversity and structure. Pathogens 2025, 14, 61. [Google Scholar] [CrossRef] [PubMed]
  16. Herreros-Cabello, A.; Callejas-Hernández, F.; Gironès, N.; Fresno, M. Trypanosoma cruzi genome: Organization, multigene families, transcription, and biological implications. Genes 2020, 11, 1196. [Google Scholar] [CrossRef]
  17. Pan, A.A.; McMahon-Pratt, D. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein. J. Immunol. 1989, 143, 1001–1008. [Google Scholar] [CrossRef]
  18. Low, H.P.; Tarleton, R.L. Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily1. Mol. Biochem. Parasitol. 1997, 88, 137–149. [Google Scholar] [CrossRef]
  19. Maslov, D.A.; Opperdoes, F.R.; Kostygov, A.Y.; Hashimi, H.; Lukeš, J.; Yurchenko, V. Recent advances in trypanosomatid research: Genome organization, expression, metabolism, taxonomy and evolution. Parasitology 2019, 146, 1–27. [Google Scholar] [CrossRef]
  20. Tarleton, R.L. The role of T cells in Trypanosoma cruzi infections. Parasitol. Today 1995, 11, 7–9. [Google Scholar] [CrossRef]
  21. Fernandes, M.C.; Andrews, N.W. Host cell invasion by Trypanosoma cruzi: A unique strategy that promotes persistence. FEMS Microbiol. Rev. 2012, 36, 734–747. [Google Scholar] [CrossRef] [PubMed]
  22. De Fuentes-Vicente, J.A.; Santos-Hernández, N.G.; Ruiz-Castillejos, C.; Espinoza-Medinilla, E.E.; Flores-Villegas, A.L.; de Alba-Alvarado, M.; Cabrera-Bravo, M.; Moreno-Rodríguez, A.; Vidal-López, D.G. What do you need to know before studying Chagas disease? A beginner’s guide. Trop. Med. Infect. Dis. 2023, 8, 360. [Google Scholar] [CrossRef] [PubMed]
  23. Machado, C.A.; Ayala, F.J. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 2001, 98, 7396–7401. [Google Scholar] [CrossRef] [PubMed]
  24. Brisse, S.; Henriksson, J.; Barnabé, C.; Douzery, E.J.; Berkvens, D.; Serrano, M.; De Carvalho, M.R.; Buck, G.A.; Dujardin, J.C.; Tibayrenc, M. Evidence for genetic exchange and hybridization in Trypanosoma cruzi based on nucleotide sequences and molecular karyotype. Infect. Genet. Evol. 2003, 2, 173–183. [Google Scholar] [CrossRef]
  25. Messenger, L.A. Genetic Diversity in Trypanosoma cruzi: Marker Development and Applications; Natural Population Structures, and Genetic Exchange Mechanisms. Ph.D. Thesis, London School of Hygiene and Tropical Medicine, London, UK, September 2014. [Google Scholar]
  26. Barnabé, C.; Neubauer, K.; Solari, A.; Tibayrenc, M. Trypanosoma cruzi: Presence of the two major phylogenetic lineages and of several lesser discrete typing units (DTUs) in Chile and Paraguay. Acta Trop. 2001, 78, 127–137. [Google Scholar] [CrossRef]
  27. Llewellyn, M.S.; Lewis, M.D.; Acosta, N.; Yeo, M.; Carrasco, H.J.; Segovia, M.; Vargas, J.; Torrico, F.; Miles, M.A.; Gaunt, M.W. Trypanosoma cruzi IIc: Phylogenetic and phylogeographic insights from sequence and microsatellite analysis and potential impact on emergent Chagas disease. PLoS Negl. Trop. Dis. 2009, 3, e510. [Google Scholar] [CrossRef]
  28. Pena, S.D.J.; Machado, C.R.; Macedo, A.M. Trypanosoma cruzi: Ancestral genomes and population structure. Mem. Inst. Oswaldo Cruz 2009, 104, 108–114. [Google Scholar] [CrossRef]
  29. Subileau, M.; Barnabé, C.; Douzery, E.J.; Diosque, P.; Tibayrenc, M. Trypanosoma cruzi: New insights on ecophylogeny and hybridization by multigene sequencing of three nuclear and one maxicircle genes. Exp. Parasitol. 2009, 122, 328–337. [Google Scholar] [CrossRef]
  30. Zingales, B.; Andrade, S.G.; Briones, M.R.; Campbell, D.A.; Chiari, E.; Fernandes, O.; Guhl, F.; Lages-Silva, E.; Macedo, A.M.; Machado, C.R.; et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: Second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 2009, 104, 1051–1054. [Google Scholar] [CrossRef]
  31. Ferreira, R.C.; Briones, M.R. Phylogenetic evidence based on Trypanosoma cruzi nuclear gene sequences and information entropy suggest that inter-strain intragenic recombination is a basic mechanism underlying the allele diversity of hybrid strains. Infect. Genet. Evol. 2012, 12, 1064–1071. [Google Scholar] [CrossRef]
  32. Bhattacharyya, T.; Murphy, N.; Miles, M.A. Trypanosoma cruzi lineage-specific serology: New rapid tests for resolving clinical and ecological associations. Future Sci. OA 2019, 5, 422. [Google Scholar] [CrossRef] [PubMed]
  33. Lima, L.; Espinosa-Álvarez, O.; Ortiz, P.A.; Trejo-Varón, J.A.; Carranza, J.C.; Pinto, C.M.; Serrano, M.G.; Buck, G.A.; Camargo, E.P.; Teixeira, M.M. Genetic diversity of Trypanosoma cruzi in bats, and multilocus phylogenetic and phylogeographical analyses supporting Tcbat as an independent DTU (discrete typing unit). Acta Trop. 2015, 151, 166–177. [Google Scholar] [CrossRef]
  34. Di Noia, J.M.; Buscaglia, C.A.; De Marchi, C.R.; Almeida, I.C.; Frasch, A.C. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas’ disease is due to a single parasite lineage. J. Exp. Med. 2002, 195, 401–413. [Google Scholar] [CrossRef] [PubMed]
  35. Grisard, E.C.; Teixeira, S.M.; de Almeida, L.G.; Stoco, P.H.; Gerber, A.L.; Talavera-López, C.; Lima, O.C.; Andersson, B.; de Vasconcelos, A.T. Trypanosoma cruzi Clone Dm28c Draft Genome Sequence. Genome Announc. 2014, 2, e01114-e13. [Google Scholar] [CrossRef] [PubMed]
  36. Franzén, O.; Ochaya, S.; Sherwood, E.; Lewis, M.D.; Llewellyn, M.S.; Miles, M.A.; Andersson, B. Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener. PLoS Negl. Trop. Dis. 2011, 5, e984. [Google Scholar] [CrossRef]
  37. Fernandes, O.; Souto, R.P.; Castro, J.A.; Pereira, J.B.; Fernandes, N.C.; Junqueira, A.C.; Naiff, R.D.; Barrett, T.V.; Degrave, W.; Zingales, B.; et al. Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. Am. J. Trop. Med. Hyg. 1998, 58, 807–811. [Google Scholar] [CrossRef]
  38. Zingales, B.; Souto, R.P.; Mangia, R.H.; Lisboa, C.V.; Campbell, D.A.; Coura, J.R.; Jansen, A.; Fernandes, O. Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences. Int. J. Parasitol. 1998, 28, 105–112. [Google Scholar] [CrossRef]
  39. Yeo, M.; Acosta, N.; Llewellyn, M.; Sánchez, H.; Adamson, S.; Miles, G.A.; López, E.; González, N.; Patterson, J.S.; Gaunt, M.W.; et al. Origins of Chagas disease: Didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids. Int. J. Parasitol. 2005, 35, 225–233. [Google Scholar] [CrossRef]
  40. Rassi, A., Jr.; Rassi, A.; Marin-Neto, J.A. Chagas disease. Lancet 2010, 375, 1388–1402. [Google Scholar] [CrossRef]
  41. Risso, M.G.; Sartor, P.A.; Burgos, J.M.; Briceño, L.; Rodríguez, E.M.; Guhl, F.; Chavez, O.T.; Espinoza, B.; Monteón, V.M.; Russomando, G.; et al. Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic area. Am. J. Trop. Med. Hyg. 2011, 84, 78–84. [Google Scholar] [CrossRef]
  42. Freitas, J.M.; Lages-Silva, E.; Crema, E.; Pena, S.D.; Macedo, A.M. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int. J. Parasitol. 2005, 35, 411–417. [Google Scholar] [CrossRef] [PubMed]
  43. Fesser, A.; Beilstein, S.; Kaiser, M.; Schmidt, R.S.; Mäser, P. Trypanosoma cruzi STIB980: A TcI strain for drug discovery and reverse genetics. Pathogens 2023, 12, 1217. [Google Scholar] [CrossRef] [PubMed]
  44. Brady, M.A.; Hooper, P.J.; Ottesen, E.A. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 2006, 22, 285–291. [Google Scholar] [CrossRef] [PubMed]
  45. Hotez, P.; Ottesen, E.; Fenwick, A.; Molyneux, D. The Neglected Tropical Diseases: The Ancient Afflictions of Stigma and Poverty and the Prospects for their Control and Elimination. In Hot Topics in Infection and Immunity in Children III; Pollard, A.J., Finn, A., Eds.; Advances in Experimental Medicine and Biology; Springer: Boston, MA, USA, 2006; Volume 582, pp. 23–33. [Google Scholar]
  46. Hotez, P.J. A7 The Neglected Tropical Diseases and the Neglected Infections of Poverty: Overview of their Common Features, Global Disease Burden and Distribution, New Control Tools, and Prospects for Disease Elimination. In Institute of Medicine (US) Forum on Microbial Threats. The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies; National Academies Press: Washington, DC, USA, 2011. [Google Scholar]
  47. Lammie, P.J.; Fenwick, A.; Utzinger, J. A blueprint for success: Integration of neglected tropical disease control programmes. Trends Parasitol. 2006, 22, 313–321. [Google Scholar] [CrossRef]
  48. Molyneux, D.H.; Hotez, P.J.; Fenwick, A. “Rapid-impact interventions”: How a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med. 2005, 2, e336. [Google Scholar] [CrossRef]
  49. Utzinger, J.; de Savigny, D. Control of neglected tropical diseases: Integrated chemotherapy and beyond. PLoS Med. 2006, 3, e112. [Google Scholar] [CrossRef]
  50. Winny, A. Chagas: The Most Neglected of Neglected Tropical Diseases; Johns Hopkins Bloomberg School of Public Health: Baltimore, MD, USA, 2022; Available online: https://publichealth.jhu.edu/2022/chagas-the-most-neglected-of-neglected-tropical-diseases (accessed on 24 April 2025).
  51. World Health Organization (WHO) Fact Sheet. Chagas Disease (Also Known as American Trypanosomiasis). 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) (accessed on 24 April 2025).
  52. Caldas, I.S.; Talvani, A.; Caldas, S.; Carneiro, C.M.; de Lana, M.; da Matta Guedes, P.M.; Bahia, M.T. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol. Res. 2008, 103, 413–421. [Google Scholar] [CrossRef]
  53. Pan, A.A.; Winkler, M.A. The threat of Chagas’ disease in transfusion medicine. The presence of antibodies to Trypanosoma cruzi in the US blood supply. Lab. Med. 1995, 28, 269–274. [Google Scholar] [CrossRef]
  54. Pan, A.A.; Rosenberg, G.B.; Hurley, M.; Schock, G.J.H.; Chu, V.P.; Aiyappa, A.A. Clinical evaluation of an EIA for the sensitive and specific detection of serum antibody to Trypanosoma cruzi (Chagas’ disease). J. Infect. Dis. 1992, 165, 585–588. [Google Scholar] [CrossRef]
  55. Brashear, R.J.; Winkler, M.A.; Schur, J.D.; Lee, H.; Burczak, J.D.; Hall, H.J.; Pan, A.A. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995, 35, 213–218. [Google Scholar]
  56. Winkler, M.A.; Brashear, R.J.; Hall, H.J.; Schur, J.D.; Pan, A.A. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity. Transfusion 1995, 35, 219–225. [Google Scholar] [CrossRef] [PubMed]
  57. Pan, S.C. Trypanosoma cruzi: Intracellular stages grown in a cell-free medium at 37 °C. Exp. Parasitol. 1978, 45, 215–224. [Google Scholar] [CrossRef] [PubMed]
  58. Winkler, M.A.; Rivera, D.M.; Pan, A.A.; Nowlan, S.F. Homology of Trypanosoma cruzi clone 36 repetitive DNA sequence to sequence encoding human Ro/SSA 52 kD autoantigen. Parasite 1998, 5, 94–95. [Google Scholar]
  59. Winkler, M.A.; Pan, A.A. Is there a link between the human TRIM21 and Trypanosoma cruzi clone 36 genes in Chagas’ disease? Mol. Immunol. 2010, 48, 365–367. [Google Scholar] [CrossRef] [PubMed]
  60. Winkler, M.A.; Pan, A.A. Molecular similarities between the genes for Trypanosoma cruzi microtubule-associated proteins, mammalian interferons, and TRIMs. Parasitol. Res. 2024, 123, 319–330. [Google Scholar] [CrossRef]
  61. Levin, M.J.; Levitus, G.; Kerner, N.; Lafon, S.; Schijman, A.; Levy-Yeyati, P.; Finkielstein, C.; Chiale, P.; Schejtman, D.; Hontebeyrie-Joskowics, M. Autoantibodies in Chagas’ heart disease: Possible markers of severe Chagas’ heart complaint. Mem. Inst. Oswaldo Cruz 1990, 85, 539–543. [Google Scholar] [CrossRef]
  62. Womble, D.D. GCG: The Wisconsin Package of sequence analysis programs. Meth. Mol. Biol. 2000, 132, 3–22. [Google Scholar]
  63. Majeau, A.; Murphy, L.; Herrera, C. Assessing Trypanosoma cruzi parasite diversity through comparative genomics: Implications for disease epidemiology and diagnostics. Pathogens 2021, 10, 212. [Google Scholar] [CrossRef]
  64. Majeau, A.; Dumonteil, E.; Herrera, C. Identification of highly conserved Trypanosoma cruzi antigens for the development of a universal serological diagnostic assay. Emerg. Microbes Infect. 2024, 13, 2315964. [Google Scholar] [CrossRef]
  65. Bhattacharyya, T.; Murphy, N.; Miles, M.A. Diversity of Chagas disease diagnostic antigens: Successes and limitations. PLoS Negl. Trop. Dis. 2024, 18, e0012512. [Google Scholar] [CrossRef]
  66. Briones, M.R.; Souto, R.P.; Stolf, B.S.; Zingales, B. The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity. Mol. Biochem. Parasitol. 1999, 104, 219–232. [Google Scholar] [CrossRef]
  67. Rozas, M.; De Doncker, S.; Coronado, X.; Barnabé, C.; Tibyarenc, M.; Solari, A.; Dujardin, J.-C. Evolutionary history of Trypanosoma cruzi according to antigen genes. Parasitology 2008, 135, 1157–1164. [Google Scholar] [CrossRef]
  68. Affolter, M.; Hemphill, A.; Roditi, I.; Müller, N.; Seebeck, T. The repetitive microtubule-associated proteins MARP-1 and MARP-2 of Trypanosoma brucei. J. Struct. Biol. 1994, 112, 241–251. [Google Scholar] [CrossRef] [PubMed]
  69. Müller, N.; Hemphill, A.; Imboden, M.; Duvallet, G.; Dwinger, R.H.; Seebeck, T. Identification and characterization of two repetitive non-variable antigens from African trypanosomes which are recognized early during infection. Parasitology 1992, 104, 111–120. [Google Scholar] [CrossRef] [PubMed]
  70. Schneider, A.; Hemphill, A.; Wyler, T.; Seebeck, T. Large microtubule-associated protein of T. brucei has tandemly repeated, near-identical sequences. Science 1988, 241, 459–462. [Google Scholar]
  71. Robinson, D.; Beattie, P.; Sherwin, T.; Gull, K. [25] Microtubules, tubulin, and microtubule-associated proteins of trypanosomes. Methods Enzymol. 1991, 196, 285–299. [Google Scholar]
  72. Akhoundi, M.; Kuhls, K.; Cannet, A.; Votýpka, J.; Marty, P.; Delaunay, P.; Sereno, D. A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies. PLoS Negl. Trop. Dis. 2016, 10, e0004349, Erratum in PLoS Negl. Trop. Dis. 2016, 10, e0004770. [Google Scholar] [CrossRef] [PubMed]
  73. Sanger, F.; Nicklen, S.; Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977, 74, 5463–5467. [Google Scholar] [CrossRef]
  74. Blankenberg, D.; Taylor, J.; Schenck, I.; He, J.; Zhang, Y.; Ghent, M.; Veeraaghavan, N.; Albert, I.; Miller, W.; Makova, K.D.; et al. A framework for collaborative analysis of ENCODE data: Making large-scale analyses biologist-friendly. Genome Res. 2007, 17, 960–964. [Google Scholar] [CrossRef]
  75. Afgan, E.; Baker, D.; Van den Beek, M.; Blankenberg, D.; Bouvier, D.; Cech, M.; Chilton, J.; Clements, D.; Coraor, N.; Eberhard, C.; et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses. Nucleic Acids Res. 2016, 44, W3–W10. [Google Scholar] [CrossRef]
  76. Ohno, S. Evolution by Gene Duplication, 1st ed.; Springer: Berlin/Heidelberg, Germany, 1970; Volume XV, p. 160. [Google Scholar]
  77. Berry, A.S.F.; Salazar-Sánchez, R.; Castillo-Neyra, R.; Borrini-Mayorí, K.; Chipana-Ramos, C.; Vargas-Maquera, M.; Ancca-Juarez, J.; Náquira-Velarde, C.; Levy, M.Z.; Brisson, D. Sexual reproduction in a natural Trypanosoma cruzi population. PLoS Negl. Trop. Dis. 2019, 13, e0007392. [Google Scholar] [CrossRef] [PubMed]
  78. Schwabl, P.; Imamura, H.; Van den Broeck, F.; Costales, J.A.; Maiguashca-Sánchez, J.; Miles, M.A.; Andersson, B.; Grijalva, M.J.; Llewellyn, M.S. Meiotic sex in Chagas disease parasite Trypanosoma cruzi. Nat. Commun. 2019, 10, 3972. [Google Scholar] [CrossRef] [PubMed]
  79. Martins, C.; Reis-Cunha, J.L.; Silva, M.N.; Pereira, E.G.; Pappas, G.J., Jr.; Bartholomeu, D.C.; Zingales, B. Identification of genes encoding hypothetical proteins in open-reading frame expressed sequence tags from mammalian stages of Trypanosoma cruzi. Genet. Mol. Res. 2011, 10, 1589–1630. [Google Scholar] [CrossRef] [PubMed]
  80. Whelan, F.J.; Yap, N.V.L.; Surette, M.G.; Golding, B.G.; Bowdish, D.M.E. A guide to bioinformatics for immunologists. Front. Immunol. 2013, 4, 416. [Google Scholar] [CrossRef]
  81. Velásquez-Ortiz, N.; Herrera, G.; Hernández, C.; Muñoz, M.; Ramírez, J.D. Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas. Sci. Data 2022, 9, 360. [Google Scholar] [CrossRef]
  82. Cáceres, T.M.; Cruz-Saavedra, L.; Patiño, L.H.; Ramírez, J.D. Comparative analysis of metacyclogenesis and infection curves in different discrete typing units of Trypanosoma cruzi. Parasitol. Res. 2024, 123, 181. [Google Scholar] [CrossRef]
  83. Barnabé, C.; Brenière, S.F.; Santillán-Guayasamín, S.; Douzery, E.J.P.; Waleck, E. Revisiting gene typing and phylogeny of Trypanosoma cruzi reference strains: Comparison of the relevance of mitochondrial DNA, single-copy nuclear DNA, and the intergenic region of mini-exon gene. Infect. Genet. Evol. 2023, 115, 105504. [Google Scholar] [CrossRef]
Figure 1. Trypanosoma cruzi antigen DNA (ENA|M21331) Ag 36 from GenBank. The internal ten-nucleotide-duplicated sequences are highlighted in blue and in blue face font.
Figure 1. Trypanosoma cruzi antigen DNA (ENA|M21331) Ag 36 from GenBank. The internal ten-nucleotide-duplicated sequences are highlighted in blue and in blue face font.
Pathogens 14 00476 g001
Figure 2. Example of an amino acid sequence comparison of Trypanosoma cruzi (GenBank PWU83737) with Ag 36. The Ag 36 amino acid sequences, repeated three times, are shown in bold face font and highlighted in blue, green and purple. Note that there is one amino acid substitution (see between the blue highlighted area, seventh nucleotide).
Figure 2. Example of an amino acid sequence comparison of Trypanosoma cruzi (GenBank PWU83737) with Ag 36. The Ag 36 amino acid sequences, repeated three times, are shown in bold face font and highlighted in blue, green and purple. Note that there is one amino acid substitution (see between the blue highlighted area, seventh nucleotide).
Pathogens 14 00476 g002
Table 1. Output matrix resulting from the BLAST-p search of Ag 36 amino acid sequence versus the Trypanosoma cruzi genome, performed at and retrieved from https://www.ncbi.nlm.nih.gov/ (accessed on 25 March 2025).
Table 1. Output matrix resulting from the BLAST-p search of Ag 36 amino acid sequence versus the Trypanosoma cruzi genome, performed at and retrieved from https://www.ncbi.nlm.nih.gov/ (accessed on 25 March 2025).
GenBank Accession Number% IdentityLength (Amino Acids)Mismatches (Nucleotides)Amino Acid Residues StartAmino Scid Residues Ende Value *% Positives
RNC3040697.3683811111484.14 × 10−17100
PWU9787497.3683811071448.82 × 10−17100
KAF828832397.22236333682.35 × 10−15100
KAF828832397.3683811451821.89 × 10−16100
KAF828832396.6673091304.22 × 10−11100
PWU8442597.3683813283651.94 × 10−16100
PWV1728397.3683811822193.99 × 10−16100
PWU8373897.3683811071445.01 × 10−16100
PWU8373897.3683813353725.01 × 10−16100
PWU8373897.3683813734105.01 × 10−16100
PWU8373897.3683814114485.01 × 10−16100
PWU8373897.3683814494865.01 × 10−16100
PWU8373897.3683814875245.01 × 10−16100
XP_80956797.29737141778.11 × 10−15100
* The “e value” is the probability that this result happened by random chance.
Table 2. Overall results of the BLAST-p search of Ag 36 amino acid sequence versus the Trypanosoma cruzi genome showing multiple copies of the Ag 36 protein sequence, performed at and retrieved from https://www.ncbi.nlm.nih.gov/. Accession identifiers are at GenBank Gene https://www.ncbi.nlm.nih.gov/gene/.
Table 2. Overall results of the BLAST-p search of Ag 36 amino acid sequence versus the Trypanosoma cruzi genome showing multiple copies of the Ag 36 protein sequence, performed at and retrieved from https://www.ncbi.nlm.nih.gov/. Accession identifiers are at GenBank Gene https://www.ncbi.nlm.nih.gov/gene/.
Descriptione Value *Percent IdentityAmino Acid LengthGenBank
Accession ID
microtubule associated protein homolog2.00 × 10−2094.5938AAB20531
microtubule-associated protein5.00 × 10−21100103RNC30144
putative microtubule-associated protein4.00 × 10−21100116KAF8291685
putative microtubule-associated protein1.00 × 10−2097.37121KAF8288266
microtubule-associated protein5.00 × 10−2097.37142RNF14378
putative microtubule-associated protein8.00 × 10−21100157PWV17285
hypothetical protein TcYC6_01241803.00 × 10−20100159KAF8291204
hypothetical protein TcBrA4_00146606.00 × 10−2097.37159KAF8288041
microtubule-associated protein3.00 × 10−1997.37166RNC29983
microtubule-associated protein1.00 × 10−1997.37170RNC47282
putative microtubule-associated protein8.00 × 10−2097.37173KAF8288373
putative microtubule-associated protein1.00 × 10−1997.37195KAF8287749
microtubule-associated protein5.00 × 10−18100227RNC30406
putative microtubule-associated protein4.00 × 10−20100233PWV17284
putative microtubule-associated protein4.00 × 10−20100234PWU83737
microtubule-associated protein-like1.00 × 10−19100235KAF8291360
microtubule-associated protein6.00 × 10−1497.06240RNC30522
MAP-TcD-TSSA-FRA-SAPA chimeric antigen3.00 × 10−13100266UGO57631
microtubule-associated protein homolog8.00 × 10−1997.37299AAD51095
hypothetical protein TcBrA4_00146303.00 × 10−1997.37310KAF8288323
microtubule-associated protein-like3.00 × 10−19100311KAF8291458
microtubule-associated protein3.00 × 10−20100321RNC47283
microtubule-associated protein-like5.00 × 10−19100363KAF8291386
putative microtubule-associated protein1.00 × 10−10100385PWV17283
microtubule-associated-like protein4.00 × 10−19100391KAF8288016
hypothetical protein TcBrA4_00146402.00 × 10−1897.37441KAF8288063
microtubule-associated protein6.00 × 10−19100555KAF8291499
putative microtubule-associated protein6.00 × 10−2197.37576PWU83738
putative microtubule-associated protein2.00 × 10−20100644PWU84425
putative microtubule-associated protein6.00 × 10−20100652PWU83735
microtubule-associated protein, putative6.00 × 10−19100738XP_803031
putative microtubule-associated protein7.00 × 10−19100990KAF8291180
microtubule-associated protein, putative4.00 × 10−191001091XP_809567
putative microtubule-associated protein3.00 × 10−191001122PWV17287
putative microtubule-associated protein6.00 × 10−191001180PWU97875
putative microtubule-associated protein4.00 × 10−201002011PWU97874
Amino Acid Length = Total amino acids in the protein; HP = Hypothetical Protein [79]; MAP = Microtubule Associated Protein Percent Identity = Percent exact matches in sequence; pMAP = putative Microtubule Associated Protein. * The “e value” is the probability that this result happened by random chance.
Table 3. Copies of the Ag 36 amino acid sequence motif reported in the BLAST-p genes of Table 2.
Table 3. Copies of the Ag 36 amino acid sequence motif reported in the BLAST-p genes of Table 2.
Accession GenBankAg 36 Motif CopiesAccession GenBankAg 36 Motif Copies
AAB205311KAF82883236
RNC301443KAF82914588
KAF82916853RNC4728317
KAF82882662KAF82913864
RNF143781PWV1728330
PWV172855KAF82880165
KAF82912044KAF828806311
KAF82880412KAF829149912
RNC299834PWU837387
RNC4728217PWU844259
KAF82883732PWU837351
KAF82877491XP_80303119
RNC304061KAF829118025
PWV172841XP_80956720
PWU837373PWV1728720
KAF829136011PWU9787530
RNC305220PWU9787417
UGO5763112Copies Sum296
AAD510951
GenBank Accessions are the genes listed from Table 2. Ag 36 motif copies are the number of copies of the Ag 36 amino acid sequences in the translated gene, as reported in the BLAST-p search of Ag 36 on the T. cruzi genome.
Table 4. Comparison in a BLAST-p search of Ag 36 in the class Kinetoplastida.
Table 4. Comparison in a BLAST-p search of Ag 36 in the class Kinetoplastida.
DescriptionOrganismPercent IdentityAccession Length
Amino Acid Residues
MAPTrypanosoma theileri83133
MAP [68]T. brucei69145
MAP [68]T. brucei69313
pMAPT. b. brucei TREU927692105
HP Tb10.v4.0053T. b. brucei TREU927694119
MAP 2T. b. brucei TREU927694880
pMAPT. b. brucei TREU927692257
pMAPT. b. gambiense DAL972691687
pMAP, (fragment)T. b. gambiense DAL972692245
HP, unlikelyT. b. gambiense DAL97265416
MAP 2T. b. equiperdum65679
UPPT. congolense IL300065440
MAP MARP-1 [70]T. brucei58192
HP, unlikelyT. b. gambiense DAL97258725
MAPTrypanosoma vivax571318
MAP P320T. b. brucei48290
HPLeishmania donovani *471124
Accession Length = total amino acids in the protein; HP = Hypothetical Protein [79]; MAP = Microtubule Associated Protein; MARP-1 = Microtubule Associated Repetitive Protein; pMAP = putative Microtubule Associated Protein; Percent Identity = percent exact matches in sequence; UPP = Unnamed Protein Product; BLAST-p search accomplished at http://ncbi.nlm.nih.gov/. * BLAST-p search performed on L. tropica and L. mexicana were similar to L. donovani with proteins that were 47% identical.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Winkler, M.A.; Pan, A.A. Molecular and Genetic Analysis of the Increased Number of Genes for Trypanosoma cruzi Microtubule Associated Proteins in the Class Kinetoplastida. Pathogens 2025, 14, 476. https://doi.org/10.3390/pathogens14050476

AMA Style

Winkler MA, Pan AA. Molecular and Genetic Analysis of the Increased Number of Genes for Trypanosoma cruzi Microtubule Associated Proteins in the Class Kinetoplastida. Pathogens. 2025; 14(5):476. https://doi.org/10.3390/pathogens14050476

Chicago/Turabian Style

Winkler, Martin A., and Alfred A. Pan. 2025. "Molecular and Genetic Analysis of the Increased Number of Genes for Trypanosoma cruzi Microtubule Associated Proteins in the Class Kinetoplastida" Pathogens 14, no. 5: 476. https://doi.org/10.3390/pathogens14050476

APA Style

Winkler, M. A., & Pan, A. A. (2025). Molecular and Genetic Analysis of the Increased Number of Genes for Trypanosoma cruzi Microtubule Associated Proteins in the Class Kinetoplastida. Pathogens, 14(5), 476. https://doi.org/10.3390/pathogens14050476

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop